Insider Holders & Insider Ownership - Catalent Inc. (CTLT)

List of insiders holdings for Catalent Inc.:
  1. Shares directly owned by the insider.
  2. Shares indirectly owned by the insider.
  3. Total shares owned by the insider (sum of shares directly and indirectly owned).
  4. Total market value if available.
  5. Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Insider Holder NameReport
Date Time		Shares Owned
Directly
Indirectly		Total
Shares Owned		Filing
Zippelius Peter
Director		2022-10-31 17:46:2411,979
4,330,462		4,342,441Form 4
Chiminski John R
Executive Chair		2022-08-26 20:16:30229,888
0		229,888Form 4
Maselli Alessandro
President & CEO		2024-07-30 16:53:51177,521
0		177,521Form 4
GREISCH JOHN J
Executive Chair		2024-07-30 17:36:1879,932
34,000		113,932Form 4
Gennadios Aristippos
Group Pres. Pharma & Consumer		2024-08-05 12:33:35113,724
0		113,724Form 4
WALSH MATTHEW M
EVP & Chief Financial Officer		2017-08-28 12:29:43103,703
0		103,703Form 4
Joseph Wetteny
SVP & Chief Financial Officer		2021-02-18 09:56:2079,227
0		79,227Form 4
Johnson Sharon
See Remarks		2017-04-27 11:02:1977,645
0		77,645Form 4
Masanovich Matti
SVP, Chief Financial Officer		2024-07-30 16:58:5676,475
0		76,475Form 4
Fasman Steven L
EVP & Chief Admin Officer		2023-12-12 19:11:2375,423
0		75,423Form 4/A
Leonard Stephen
See Remarks		2016-07-28 19:21:1273,140
0		73,140Form 4
MOREL DONALD E JR
Director		2024-11-01 17:07:5570,118
0		70,118Form 4
Arnold Jonathan
SVP, CCO & Div. Head BioP Del.		2023-12-12 18:58:2057,573
0		57,573Form 4/A
Kurt Nielsen
See Remarks		2015-02-19 19:28:3557,156
0		57,156Form 4/A
Dolan Christine
SVP - Product Development		2017-08-31 10:41:2653,736
0		53,736Form 4
CLASSON ROLF A
Director		2024-11-01 16:54:2347,984
0		47,984Form 4
STAHL JACK L
Director		2024-11-01 16:48:1947,984
0		47,984Form 4
Miyamoto Lance
SVP, Human Resources		2019-03-11 19:31:1446,799
0		46,799Form 4
Downie William
SVP, Global Sales & Marketing		2019-02-20 15:48:5246,662
0		46,662Form 4
BUZY PETER L
President, Gene Therapy		2020-04-13 12:12:2645,950
0		45,950Form 4
Littlejohns Barry
President, Biologics & SDD		2019-08-26 15:49:3245,882
0		45,882Form 4
Gunther Scott
SVP, Quality & Reg. Affairs		2024-08-05 12:51:0539,635
0		39,635Form 4
Evoli Lisa
SVP, Chief HR Officer		2024-08-05 12:39:5739,366
0		39,366Form 4
LUCIER GREGORY T
Director		2024-11-01 16:58:5436,914
0		36,914Form 4
McErlane David
Group President, Biologics		2024-09-27 12:01:2336,304
0		36,304Form 4
CARROLL J MARTIN
Director		2024-11-01 17:04:2232,734
0		32,734Form 4
Pravda Ricardo
Chief Transformation Officer		2023-12-12 19:21:4030,982
0		30,982Form 4/A
Hopson Ricky
Pres. BioProduct Delivery, CoS		2024-08-05 12:55:5029,974
0		29,974Form 4
Balachandran Madhavan
Director		2023-10-31 17:07:4027,441
0		27,441Form 4
Grippo Michael J
SVP, Strategy & Corp. Dev.		2023-12-12 19:05:2525,229
0		25,229Form 4/A
Flynn Karen
Director		2023-10-31 17:00:5424,339
0		24,339Form 4
Ferraro Joseph Anthony
SVP, General Counsel, CCO		2024-10-21 11:30:3123,967
0		23,967Form 4
Crane Rosemary A
Director		2023-10-31 17:02:0823,873
0		23,873Form 4
QUELLA JAMES
Director		2017-08-28 11:31:4820,641
0		20,641Form 4
Castellano Thomas P
SVP, Chief Financial Officer		2022-08-26 20:16:0320,099
0		20,099Form 4
Kreuzburg Christa
Director		2024-01-29 16:09:0518,283
0		18,283Form 4
Barber Michael J
Director		2024-11-01 17:11:1418,052
0		18,052Form 4
Schmidt Kay A
SVP, Enterprise Functions		2022-08-26 20:23:5917,388
0		17,388Form 4
BOOTH MELVIN D
Director		2016-08-26 14:56:5016,665
0		16,665Form 4
Roehrhoff Uwe
Director		2017-11-22 16:25:2816,489
0		16,489Form 4
Houlton Scott
See Remarks		2015-09-04 17:39:2716,380
0		16,380Form 4
Zayas Ricardo
SVP, Operations, Biologics NA		2023-08-03 17:17:2316,101
0		16,101Form 4
Boerman Manja
Pres. BioModalities Division		2023-05-03 19:00:3714,414
0		14,414Form 4
Hatzfeld Michael
Chief Accounting Officer		2024-07-30 17:26:5413,532
0		13,532Form 4
DAMELIO FRANK A
Director		2024-11-01 17:14:2112,635
0		12,635Form 4
Okey Stephanie
Director		2024-11-01 17:17:2912,635
0		12,635Form 4
Barg Steven
Director		2024-11-01 17:23:5712,374
0		12,374Form 4
HEGWOOD PAUL W JR
President, CSS		2019-08-26 15:48:2611,848
0		11,848Form 4
Lickfold Charles
SVP, CIO		2023-12-12 19:19:5411,719
0		11,719Form 4/A
Hunt Patricia
Pres. Consumer Health Div		2023-12-12 19:17:5111,501
0		11,501Form 4/A
Ryan Michelle R
Director		2024-11-14 14:46:2310,835
0		10,835Form 4
Santiago Karen Murphy
VP & Chief Accounting Officer		2023-08-03 17:21:219,979
0		9,979Form 4
Carletti Lorenzo
SVP Global Ops Ph & Cons Hlth		2023-12-12 19:09:149,178
0		9,178Form 4/A
Hawkeswood Thomas W
Pres. Pharma Prod Delivery Div		2023-12-12 19:16:027,827
0		7,827Form 4/A
Riley Michael A.
Pres. Bio Product Delivery Div		2022-08-30 14:38:016,592
0		6,592Form 4
Gargiulo Mario
SVP, Ops, Biologics Europe		2023-05-03 18:58:005,676
0		5,676Form 4
Whitlow Ricci S
President, CSS		2022-01-24 16:42:462,923
0		2,923Form 4
Blackstone Management Associates V L.L.C.
Blackstone Healthcare Partners L.L.C.
BLACKSTONE CAPITAL PARTNERS V L P
BMA V L.L.C.
Blackstone Holdings III L.P.
Blackstone Holdings III GP L.P.
Blackstone Holdings III GP Management L.L.C.
Blackstone Group L.P.
Blackstone Group Management L.L.C.
SCHWARZMAN STEPHEN A
10% Owner		2017-02-14 14:25:560
0		0Form 13G
Chu Chinh
Director		2014-07-31 20:29:590
0		0Form 3
McEvoy Bruce
Director		2014-07-31 20:19:300
0		0Form 3